Molecular Imaging of Microglia/macrophages in the Brain

Overview

Journal Glia

Specialty Neurology

Date 2012 May 23

PMID 22615180

Citations 91

Authors

Sriram Venneti

Brian J Lopresti

Clayton A Wiley

Affiliations

Soon will be listed here.

Abstract

Neuroinflammation perpetuates neuronal damage in many neurological disorders. Activation of resident microglia and infiltration of monocytes/macrophages contributes to neuronal injury and synaptic damage. Noninvasive imaging of these cells in vivo provides a means to monitor progression of disease as well as assess efficacies of potential therapeutics. This review provides an overview of positron emission tomography (PET) and magnetic resonance (MR) imaging of microglia/macrophages in the brain. We describe the rationale behind PET imaging of microglia/macrophages with ligands that bind to translocator protein-18 kDa (TSPO). We discuss the prototype TSPO radioligand [(11)C]PK11195, its limitations, and the development of newer TSPO ligands as PET imaging agents. PET imaging agents for targets other than TSPO are emerging, and we outline the potential of these agents for imaging brain microglia/macrophage activity in vivo. Finally, we briefly summarize advances in MR imaging of microglia/macrophages using iron oxide nanoparticles and ultra-small super paramagnetic particles that are phagocytosed. Despite many technical advances, more sensitive agents are required to be useful indicators of neuroinflammation in brain.

Citing Articles

Characteristics of TSPO expression in marmoset EAE.

Falk I, Maric D, Leibovitch E, Sati P, Lefeuvre J, Luciano N J Neuroinflammation. 2025; 22(1):19.

PMID: 39871344 PMC: 11773908. DOI: 10.1186/s12974-025-03343-4.

Effects of intravascular administration of mesenchymal stromal cells derived from Wharton's Jelly of the umbilical cord on systemic immunomodulation and neuroinflammation after traumatic brain injury (TRAUMACELL): study protocol for a multicentre....

Sigaut S, Tardivon C, Jacquens A, Bottlaender M, Gervais P, Habert M BMJ Open. 2024; 14(12):e091441.

PMID: 39740941 PMC: 11749534. DOI: 10.1136/bmjopen-2024-091441.

Global research trends on the links between NfL and neurological disorders: A bibliometric analysis and review.

Song Z, Zhang S, Pan H, Hu B, Liu X, Cui J Heliyon. 2024; 10(15):e34720.

PMID: 39157316 PMC: 11327529. DOI: 10.1016/j.heliyon.2024.e34720.

Glia as a New Target for Therapeutic Actions of Electroconvulsive Therapy.

Hashioka S CNS Neurol Disord Drug Targets. 2024; 24(1):2-6.

PMID: 39005123 DOI: 10.2174/0118715273319405240707164638.

Evidence for inflammation in normal-appearing brain regions in patients with growing sporadic vestibular schwannoma: A PET study.

Alfaifi B, Hinz R, Jackson A, Wadeson A, Pathmanaban O, Hammerbeck-Ward C Neurooncol Adv. 2024; 6(1):vdae094.

PMID: 38962752 PMC: 11221070. DOI: 10.1093/noajnl/vdae094.

References

Everett H, McFadden G . Viruses and apoptosis: meddling with mitochondria. Virology. 2001; 288(1):1-7. DOI: 10.1006/viro.2001.1081. View

Maeda J, Higuchi M, Inaji M, Ji B, Haneda E, Okauchi T . Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor. Brain Res. 2007; 1157:100-11. DOI: 10.1016/j.brainres.2007.04.054. View

Price G, Ahier R, Hume S, Myers R, Manjil L, Cremer J . In vivo binding to peripheral benzodiazepine binding sites in lesioned rat brain: comparison between [3H]PK11195 and [18F]PK14105 as markers for neuronal damage. J Neurochem. 1990; 55(1):175-85. DOI: 10.1111/j.1471-4159.1990.tb08836.x. View

Delmas P, Shire D, Ferrara P . Topological analysis of the peripheral benzodiazepine receptor in yeast mitochondrial membranes supports a five-transmembrane structure. J Biol Chem. 1998; 273(4):2146-52. DOI: 10.1074/jbc.273.4.2146. View

Giulian D, Baker T, Shih L, Lachman L . Interleukin 1 of the central nervous system is produced by ameboid microglia. J Exp Med. 1986; 164(2):594-604. PMC: 2188228. DOI: 10.1084/jem.164.2.594. View

Righi M, Mori L, De Libero G, Sironi M, Biondi A, Mantovani A . Monokine production by microglial cell clones. Eur J Immunol. 1989; 19(8):1443-8. DOI: 10.1002/eji.1830190815. View

Chen M, Baidoo K, Verina T, Guilarte T . Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization. Brain. 2004; 127(Pt 6):1379-92. DOI: 10.1093/brain/awh161. View

Rupprecht R, Papadopoulos V, Rammes G, Baghai T, Fan J, Akula N . Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov. 2010; 9(12):971-88. DOI: 10.1038/nrd3295. View

Kropholler M, Boellaard R, Schuitemaker A, Folkersma H, van Berckel B, Lammertsma A . Evaluation of reference tissue models for the analysis of [11C](R)-PK11195 studies. J Cereb Blood Flow Metab. 2006; 26(11):1431-41. DOI: 10.1038/sj.jcbfm.9600289. View

10.

Banati R, Newcombe J, Gunn R, Cagnin A, Turkheimer F, Heppner F . The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain. 2000; 123 ( Pt 11):2321-37. DOI: 10.1093/brain/123.11.2321. View

11.

Awad M, Gavish M . Peripheral-type benzodiazepine receptors in human cerebral cortex, kidney, and colon. Life Sci. 1991; 49(16):1155-61. DOI: 10.1016/0024-3205(91)90562-p. View

12.

Marik J, Ogasawara A, Martin-McNulty B, Ross J, Flores J, Gill H . PET of glial metabolism using 2-18F-fluoroacetate. J Nucl Med. 2009; 50(6):982-90. DOI: 10.2967/jnumed.108.057356. View

13.

Papadopoulos V, Lecanu L, Brown R, Han Z, Yao Z . Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Neuroscience. 2005; 138(3):749-56. DOI: 10.1016/j.neuroscience.2005.05.063. View

14.

Venneti S, Lopresti B, Wiley C . The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging. Prog Neurobiol. 2006; 80(6):308-22. PMC: 1849976. DOI: 10.1016/j.pneurobio.2006.10.002. View

15.

Jander S, Schroeter M, Saleh A . Imaging inflammation in acute brain ischemia. Stroke. 2007; 38(2 Suppl):642-5. DOI: 10.1161/01.STR.0000250048.42916.ad. View

16.

Flogel U, Ding Z, Hardung H, Jander S, Reichmann G, Jacoby C . In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation. 2008; 118(2):140-8. PMC: 2735653. DOI: 10.1161/CIRCULATIONAHA.107.737890. View

17.

Charbonneau P, Syrota A, Crouzel C, Valois J, Prenant C, Crouzel M . Peripheral-type benzodiazepine receptors in the living heart characterized by positron emission tomography. Circulation. 1986; 73(3):476-83. DOI: 10.1161/01.cir.73.3.476. View

18.

Banati R, Myers R, Kreutzberg G . PK ('peripheral benzodiazepine')--binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia. J Neurocytol. 1997; 26(2):77-82. DOI: 10.1023/a:1018567510105. View

19.

Stephenson F . The GABAA receptors. Biochem J. 1995; 310 ( Pt 1):1-9. PMC: 1135846. DOI: 10.1042/bj3100001. View

20.

Hirsch J, Beyer C, Malkowitz L, Beer B, Blume A . Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control. Mol Pharmacol. 1989; 35(1):157-63. View